Ysios Capital Partners SGECR SA
Barcelona, Spain · Seed → Series B
Their stated focus (public profile)
Ysios Capital is a leading European life sciences venture capital firm investing globally in highly innovative biotech companies developing novel therapeutics for indications with high unmet medical needs. The firm focuses on asset-centric companies and product-enabling platform technologies with proprietary products, targeting exceptional teams with pioneering science. It also has an explicit ESG and impact mandate, measuring performance at both the fund and portfolio level.
Stages: Seed → Series B
Sectors: Life sciences, Medtech
On file: 10 partners on record · 25 companies on record
Website: ysioscapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.